Swedbank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-170,643
Closed -$13.8M 701
2025
Q1
$13.8M Sell
170,643
-60,558
-26% -$5.41M 0.02% 422
2024
Q4
$20.8M Hold
231,201
0.03% 342
2024
Q3
$22.8M Buy
+231,201
New +$22.7M 0.03% 326

Other funds holding XBI

Swedbank's XBI Position: Q2 2025 in Review

Swedbank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 170,643 shares — an estimated $13.8M sold.

Swedbank first reported a position in XBI in Q3 2024 and held it in 3 quarters. The position peaked at $22.8M in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • Swedbank reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Swedbank sold 170,643 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $13.8M.
  • Swedbank first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and held it in 3 quarters.
  • Swedbank's State Street SPDR S&P Biotech ETF position peaked at $22.8M in Q3 2024.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Swedbank's 13F filing for Q2 2025, filed 10 Jul 2025.